Statement re Artemis collaboration (1334P)
29 September 2011 - 8:00AM
UK Regulatory
TIDMXCT
RNS Number : 1334P
XCounter AB
29 September 2011
PRESS RELEASE
Stockholm, 29 September 2011
XCounter delivers 1(st) prototype of the new photon counting
detector to Artemis Imaging GbmH
XCounter AB (AIM: XCT) ("XCounter" or the "Company"), a
technology leader in the development and supply of specialty X-ray
detectors, announces the delivery of its first detector prototype
based on the Company's state of the art photon counting technology
(PCT) to its customer Artemis Imaging GmbH ("Artemis"). This
delivery forms part of the ongoing development collaboration in
which Artemis is developing an innovative 3-D mammography CT
system.
The new breast imaging system will incorporate XCounter's
innovative digital photon counting solid state detector platform,
which enables fast, high quality 3-D imaging with the lowest
possible radiation dose.
Under the collaboration agreement, the commencement of which was
announced in December 2010, Artemis is funding XCounter's Mammo-CT
detector development including delivery of a fully functioning
detector prototype.
For further information, please contact:
XCounter AB Tel: +46 (0) 8 622 23 00 Mikael Strindlund, CEO
Nomura Code Securities Tel: +44 (0) 20 7776 1200 Phil
Walker/Clare Terlouw
Capital MS&L Tel: +44 (0) 207 307 5330 Anna Davies
About XCounter AB XCounter AB is a leader in the development and
supply of direct conversion, photon counting and tomosynthesis
based 3D X-ray imaging technologies for medical, dental and
industrial X-ray imaging.
Headquartered in Stockholm, XCounter employs 28 people in its
facilities in Sweden and Finland. For more detailed information,
please visit: www.xcounter.se
This information is provided by RNS
The company news service from the London Stock Exchange
END
STREVLFLFKFXBBV
Xcounter (LSE:XCT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Xcounter (LSE:XCT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024